Boots chief quits after Walgreens' sale plan stalls
Adds CEO's full name in paragraph 2
June 29 (Reuters) -The boss of British health and beauty retailer Boots is quitting after U.S. owner Walgreens Boots Alliance's WBA.O plans for a sale or stock market listing of the chain stalled, according to a person with knowledge of the situation.
Sebastian James, who has run Boots since 2018, will remain in the post until November before taking up a new role elsewhere, the person told Reuters.
Walgreens did not respond to Reuters' request for comment outside business hours.
Sky News first reported James' exit, saying he had taken a role in the healthcare industry.
On Thursday, Walgreens warned on its profit outlook and said it had no plans to sell Boots, having decided to continue to invest in it.
($1 = 0.7910 pounds)
Reporting by Gnaneshwar Rajan in Bengaluru and James Davey in London; Editing by Andrew Heavens, David Holmes and Clelia Oziel
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
